Cullinan Therapeutics CGEM
NASDAQ CGEM
$15.51 +0.98 (+6.74%)
At close: Oct 2, 2026 · 4:00 PM EDT

Cullinan Therapeutics (CGEM) Cash from Investing Activities (2020 - 2026)

Updated

Cullinan Therapeutics (CGEM) recorded Cash from Investing Activities of $40.68 million in Q2 2026, down 23.8% from $53.4 million a year earlier but up 25.5% from the prior quarter.

Analysis

Cullinan Therapeutics (CGEM) Cash from Investing Activities (2020 - 2026) Analysis & Trends

On a TTM basis, Cullinan Therapeutics' Cash from Investing Activities came in at $162.88 million as of Jun 30, 2026, up 29.2% year-over-year; for FY2025, it came in at $179.99 million.

  • Across earlier years, Cash from Investing Activities came in at -$136.31 million in FY2024, $35.81 million in FY2023 (-85.6%), $248.98 million in FY2022 and -$333.78 million in FY2021.
  • Quarterly Cash from Investing Activities has ranged from -$185.11 million in Q2 2024 to $300.85 million in Q2 2022 over the past five years.
  • On a year-over-year basis, Cash from Investing Activities rose in three of the last six quarters, with growth averaging 59.8%.
  • Peak year-over-year performance for Cash from Investing Activities in the last five years was growth of 239.0% in Q3 2025, against a decline of 96.0% in Q2 2023 at the low end.
  • Per Business Quant, the preceding three quarters came in at $32.41 million (Q1 2026), $22.39 million (Q4 2025) and $67.39 million (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash from Investing (Qtr)
1 Eli Lilly 1,076.25 Bn 1,044.84 Bn 19.71 Bn -15.40 Bn
2 Johnson & Johnson 617.18 Bn 535.70 Bn 17.26 Bn -1.11 Bn
3 AbbVie 464.58 Bn 437.73 Bn 12.70 Bn -1.20 Bn
4 Merck 356.04 Bn 310.47 Bn 12.21 Bn -5.60 Bn
5 Novartis Ag 269.07 Bn 224.94 Bn 11.24 Bn -3.11 Bn
6 Astrazeneca 243.21 Bn 216.77 Bn 12.86 Bn -2.91 Bn
7 Amgen 217.88 Bn 173.28 Bn 7.24 Bn -569.00 Mn
8 Gilead Sciences 179.62 Bn 153.74 Bn 6.22 Bn -10.35 Bn
9 Pfizer 158.45 Bn 105.40 Bn 10.94 Bn 2.11 Bn
10 Cullinan Therapeutics 998.00 Mn 998.00 Mn - 40.68 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 40.68 Mn
Mar 31, 2026 32.41 Mn
Dec 31, 2025 22.39 Mn
Sep 30, 2025 67.39 Mn
Jun 30, 2025 53.40 Mn
Mar 31, 2025 36.81 Mn
Dec 31, 2024 15.96 Mn
Sep 30, 2024 19.88 Mn
Jun 30, 2024 -185.11 Mn
Mar 31, 2024 12.96 Mn
Dec 31, 2023 51.47 Mn
Sep 30, 2023 -42.96 Mn
Jun 30, 2023 12.11 Mn
Mar 31, 2023 15.18 Mn
Dec 31, 2022 -28.61 Mn
Sep 30, 2022 -57.98 Mn
Jun 30, 2022 300.85 Mn
Mar 31, 2022 34.71 Mn
Dec 31, 2021 -15.86 Mn
Sep 30, 2021 -25.59 Mn
API Access

Cullinan Therapeutics Cash from Investing Activities API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=cash-from-investing-activities&ticker=CGEM&period=max&api_key=YOUR_API_KEY